Lilly’s reps presented a slide deck that laid out data on the effectiveness of Lilly’s weight-loss drug Zepbound. The goal of ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Jim Gaffigan has struggled with his weight for most of his adult life, but it seems that his most recent 50-lb weight loss is ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...